Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;36(1):93-102.
doi: 10.1007/s00384-020-03727-3. Epub 2020 Sep 3.

Abdominal pain in quiescent inflammatory bowel disease

Matthew D Coates  1 , Ansh Johri  2 , Venkata Subhash Gorrepati  3 , Parth Maheshwari  2 , Shannon Dalessio  3 , Vonn Walter  4 , August Stuart  3 , Walter Koltun  5 , Nana Bernasko  3 , Andrew Tinsley  3 , Emmanuelle D Williams  3 , Kofi Clarke  3
Affiliations

Abdominal pain in quiescent inflammatory bowel disease

Matthew D Coates et al. Int J Colorectal Dis. 2021 Jan.

Abstract

Objectives: Inflammation is an important driver of abdominal pain in inflammatory bowel disease (IBD). However, some patients in remission still experience pain. We aimed to identify risk factors associated with abdominal pain in quiescent IBD (QP-IBD) and to characterize differences from patients with active disease experiencing pain (AP-IBD).

Methods: We performed a retrospective analysis utilizing data from our institution's IBD Natural History Registry (January 1, 2015-August 31, 2018). Endoscopic evaluation, concurrent laboratory studies, and validated surveys were completed by participants. Demographic and clinical data were also abstracted.

Results: We recruited 122 patients with quiescent disease (65f:57 m; 93CD:26UC:3Indeterminate) for participation in this study, 74 (60.7%) had QP-IBD. QP-IBD patients were more likely to have anxiety/depression (71.6% vs. 25.0%, p < 0.001) or to use antidepressants (47.3% vs. 22.9%, p < 0.010), opiates (18.9% vs. 2.1%, p < 0.010), other pain medications (50.0% vs. 18.8%, p < 0.010), or corticosteroids (18.9% vs. 2.1%, p < 0.010). On logistic regression analysis, corticosteroid use, anxious/depressed state, and female gender were each independently associated with QP-IBD (p < 0.050 or less). Compared with AP-IBD patients (n = 110, 59f:51 m; 69CD:38UC:3Indeterminate), QP-IBD patients were more likely to use antidepressants (45.6% vs. 26.4%, p < 0.010). Platelet, white blood cell, C-reactive protein, and sedimentation rate levels were all less likely to be elevated in QP-IBD (all p < 0.050), though 44% exhibited pathological elevation in at least one.

Discussion: QP-IBD was independently associated with corticosteroid use, anxiety/depression, and female gender. Compared with AP-IBD, QP-IBD patients were more likely to use antidepressants and less likely to exhibit elevated inflammatory markers. However, many QP-IBD patients still demonstrated pathological elevation of these tests, demonstrating the need to develop new noninvasive screening methods for this condition.

Keywords: Abdominal pain; Crohn’s disease; Inflammatory bowel disease; Quiescent; Ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest/Financial disclosures: The authors of this manuscript have no relevant conflicts of interest or financial disclosures to report.

References

    1. Bielefeldt K, Davis B, Binion DG (2009) Pain and inflammatory bowel disease. Inflamm Bowel Dis 15 (5):778–788. doi: 10.1002/ibd.20848 - DOI - PMC - PubMed
    1. Coates MD, Lahoti M, Binion DG, Szigethy EM, Regueiro MD, Bielefeldt K (2013) Abdominal pain in ulcerative colitis. Inflamm Bowel Dis 19 (10):2207–2214. doi: 10.1097/MIB.0b013e31829614c6 - DOI - PMC - PubMed
    1. Zeitz J, Ak M, Muller-Mottet S, Scharl S, Biedermann L, Fournier N, Frei P, Pittet V, Scharl M, Fried M, Rogler G, Vavricka S, Swiss IBDCSG(2016) Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account. PLoS One 11 (6):e0156666. doi: 10.1371/journal.pone.0156666 - DOI - PMC - PubMed
    1. Schirbel A, Reichert A, Roll S, Baumgart DC, Buning C, Wittig B, Wiedenmann B, Dignass A, Sturm A (2010) Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol 16 (25):3168–3177. doi: 10.3748/wjg.v16.i25.3168 - DOI - PMC - PubMed
    1. Kim ES, Cho KB, Park KS, Jang BI, Kim KO, Jeon SW, Jung MK, Kim EY, Yang CH, Daegukyungbook Gastrointestinal Study G (2013) Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders. J Clin Gastroenterol 47 (4):e38–44. doi: 10.1097/MCG.0b013e318266fff5 - DOI - PubMed